recall
saveGranules Pharmaceuticals Inc. recall (Cls II)
community read0 votes
Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, — Reason: Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term. — Status: Ongoing
view source ↗Data sources
last refreshed 1m ago
Found something off?
same company · ±60 days · 6
- recallLupin Pharmaceuticals Inc. recall (Cls II)Jul 23, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Jun 18, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls III)Jun 18, 2025
- recallLupin Pharmaceuticals Inc. recall (Cls II)Jul 30, 2025
- recallHikma Pharmaceuticals USA Inc. recall (Cls II)Aug 6, 2025
- recallLupin Pharmaceuticals Inc. recall (Cls II)Aug 6, 2025
comments(0)
5-min edit window · permanent after that